A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100mg or 150mg: 1. Contraceptive efficacy and side effects
- 1 September 1986
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 34 (3) , 223-235
- https://doi.org/10.1016/0010-7824(86)90004-1
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Life‐table methods for contraceptive researchStatistics in Medicine, 1986
- Ovarian function following a single administration of depomedroxyprogesterone acetate (DMPA) at different dosesFertility and Sterility, 1984
- Multinational comparative clinical trial of long-acting injectable contraceptives: Norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report: Who special programme of research, development and research training in human reproductionContraception, 1983
- Pharmacokinetic study of different doses of Depo ProveraContraception, 1980
- RETURN OF FERTILITY AFTER DISCONTINUATION OF DEPOT MEDROXYPROGESTERONE ACETATE AND INTRA-UTERINE DEVICES IN NORTHERN THAILANDThe Lancet, 1980